We all know there is a significant increase in data collected from wearable sensors, but what does that mean for eCOA? In our latest white paper, Mark Wade, Global Practice Leader for TransPerfect Life Sciences, examines the considerations of adopting these sensors as an addition to the typical clinical outcome assessment (COA) tools used routinely today.

What are the impacts on a study team? What are the considerations in selecting these modalities? How does consumer grade compare to industrial grade? Download the white paper now to learn about the use of wearables as eCOA tools.

In this whitepaper we re-explore the benefits and drawbacks of the traditional, paper-based outcomes assessment method, as well as the advantages of the emerging electronic clinical outcomes assessment (eCOA) solutions. With each having the potential to affect data quality, timelines, and overall trial cost, the choice between them is a much discussed topic.

Monitoring the health of your eTMF is a lot like monitoring your personal health. Staying in front of it can prevent disease or provide the opportunity for early intervention should an issue come up. At TransPerfect, we consult with many clients during implementation of a eTMF and study start-up solutions on best practices for measuring KPIs. Download this report to get some examples of metrics and documentation that we feel are important in order to effectively measure performance.